May 28, 2026 07:00AM
May 28, 2026 07:00AM
May 15, 2026 07:00AM
Apr 17, 2026 07:01AM
Apr 17, 2026 07:00AM
Apr 8, 2026 07:02AM
Apr 8, 2026 07:00AM BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions
Apr 2, 2026 06:43AM
Apr 1, 2026 07:03AM
Apr 1, 2026 07:01AM
Apr 1, 2026 07:00AM
Apr 1, 2026 07:00AM
Mar 27, 2026 07:00AM
Mar 17, 2026 07:57AM Rodman & Renshaw Starts BioXcel Therapeutics (BTAI) at Buy, PT $17
Mar 5, 2026 07:00AM
Mar 5, 2026 07:00AM
Feb 19, 2026 07:00AM
Feb 12, 2026 07:01AM
Feb 12, 2026 07:00AM
Jan 20, 2026 07:01AM
Jan 20, 2026 07:00AM BioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for IGALMI® Label Expansion in the At-Home Setting
Jan 12, 2026 07:00AM
Jan 7, 2026 07:00AM
Jan 7, 2026 07:00AM
Nov 12, 2025 07:00AM
Oct 17, 2025 06:48AM
Oct 14, 2025 07:03AM
Oct 14, 2025 07:00AM BioXcel Therapeutics Announces Positive Results from Correlation Study Supporting SERENITY At-Home Exploratory Efficacy Outcomes
Sep 22, 2025 06:47AM
Sep 18, 2025 07:00AM
Sep 18, 2025 07:00AM
Sep 10, 2025 06:30AM
Sep 10, 2025 06:30AM
Sep 4, 2025 07:00AM
Aug 27, 2025 08:01AM BioXcel announces positive results from IGALMI at-home trial
Aug 27, 2025 08:00AM
Aug 27, 2025 07:00AM
Aug 27, 2025 07:00AM
Aug 27, 2025 07:00AM
Aug 26, 2025 04:00PM
Aug 26, 2025 04:00PM
Aug 19, 2025 07:00AM BioXcel completes database lock for BXCL501 agitation trial
Aug 19, 2025 07:00AM
Aug 18, 2025 07:00AM
Aug 18, 2025 07:00AM
Aug 18, 2025 06:48AM
Aug 15, 2025 09:36AM
Aug 13, 2025 07:00AM
Aug 12, 2025 07:55AM BioXcel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Updates
Aug 6, 2025 07:01AM

322,184 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All